SPROUT PHARMACEUTICALS, INC.
|SPROUT PHARMACEUTICALS, INC. Patent applications|
|Patent application number||Title||Published|
|20150011564||Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity - The present invention pertains to a compound of formula (I)||01-08-2015|
|20140005203||Treatment of Vasomotor Symptoms||01-02-2014|
|20130209519||FORMULATIONS OF FLIBANSERIN - The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin.||08-15-2013|
|20130079355||Use of Flibanserin in the Treatment of Obesity - The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin.||03-28-2013|
|20120270883||USE OF A POLYMORPH OF FLIBANSERIN FOR TREATING DISEASE - The invention relates to the polymorph A of flibanserin, to a technical process for the preparation thereof, as well as to the use thereof for preparing medicaments.||10-25-2012|
Patent applications by SPROUT PHARMACEUTICALS, INC.